247 related articles for article (PubMed ID: 25742116)
1. In vitro enrichment of ovarian cancer tumor-initiating cells.
House CD; Hernandez L; Annunziata CM
J Vis Exp; 2015 Feb; (96):. PubMed ID: 25742116
[TBL] [Abstract][Full Text] [Related]
2. Is sphere assay useful for the identification of cancer initiating cells of the ovary?
Martínez-Serrano MJ; Caballero-Baños M; Vilella R; Vidal L; Pahisa J; Martínez-Roman S
Int J Gynecol Cancer; 2015 Jan; 25(1):12-7. PubMed ID: 25365589
[TBL] [Abstract][Full Text] [Related]
3. Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells.
Zhang Y; Sun B; Zhao X; Sun H; Cui W; Liu Z; Yao X; Dong X
J Exp Clin Cancer Res; 2016 Oct; 35(1):163. PubMed ID: 27756344
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells.
Gao W; Wu D; Wang Y; Wang Z; Zou C; Dai Y; Ng CF; Teoh JY; Chan FL
Stem Cell Res Ther; 2018 Sep; 9(1):243. PubMed ID: 30257704
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer stem cells enrichment.
Yang L; Lai D
Methods Mol Biol; 2013; 1049():337-45. PubMed ID: 23913228
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor.
Liu KC; Yo YT; Huang RL; Wang YC; Liao YP; Huang TS; Chao TK; Lin CK; Weng SJ; Ma KH; Chang CC; Yu MH; Lai HC
Oncotarget; 2013 Dec; 4(12):2366-82. PubMed ID: 24280306
[TBL] [Abstract][Full Text] [Related]
7. Enrichment for chemoresistant ovarian cancer stem cells from human cell lines.
Cole JM; Joseph S; Sudhahar CG; Cowden Dahl KD
J Vis Exp; 2014 Sep; (91):51891. PubMed ID: 25285606
[TBL] [Abstract][Full Text] [Related]
8. Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function.
Leuchte K; Altvater B; Hoffschlag S; Potratz J; Meltzer J; Clemens D; Luecke A; Hardes J; Dirksen U; Juergens H; Kailayangiri S; Rossig C
Oncol Rep; 2014 Aug; 32(2):845-52. PubMed ID: 24927333
[TBL] [Abstract][Full Text] [Related]
9. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
10. LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer.
Chao TK; Yo YT; Liao YP; Wang YC; Su PH; Huang TS; Lai HC
Gynecol Oncol; 2013 Mar; 128(3):475-82. PubMed ID: 23270808
[TBL] [Abstract][Full Text] [Related]
11. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.
Dieter SM; Ball CR; Hoffmann CM; Nowrouzi A; Herbst F; Zavidij O; Abel U; Arens A; Weichert W; Brand K; Koch M; Weitz J; Schmidt M; von Kalle C; Glimm H
Cell Stem Cell; 2011 Oct; 9(4):357-65. PubMed ID: 21982235
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines.
Mo J; Sun B; Zhao X; Gu Q; Dong X; Liu Z; Ma Y; Zhao N; Liu Y; Chi J; Sun R
Melanoma Res; 2013 Aug; 23(4):254-63. PubMed ID: 23752306
[TBL] [Abstract][Full Text] [Related]
13. Establishment of human ovarian serous carcinomas cell lines in serum free media.
Pan Z; Hooley J; Smith DH; Young P; Roberts PE; Mather JP
Methods; 2012 Mar; 56(3):432-9. PubMed ID: 22445873
[TBL] [Abstract][Full Text] [Related]
14. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
[TBL] [Abstract][Full Text] [Related]
15. Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification.
Zhang H; Yang Y; Wang Y; Gao X; Wang W; Liu H; He H; Liang Y; Pan K; Wu H; Shi J; Xue H; Liang L; Cai Z; Fan Y; Zhang Y
J Ovarian Res; 2015 Mar; 8():19. PubMed ID: 25886959
[TBL] [Abstract][Full Text] [Related]
16. Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigm.
Garson K; Vanderhyden BC
Reproduction; 2015 Feb; 149(2):R59-70. PubMed ID: 25301968
[TBL] [Abstract][Full Text] [Related]
17. In vitro enrichment of tumor-initiating cells from human established cell lines.
Benayoun L; Shaked Y
Curr Protoc Stem Cell Biol; 2013 Feb; Chapter 3():Unit 3.7. PubMed ID: 23404675
[TBL] [Abstract][Full Text] [Related]
18. Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens.
Yao X; Dong Z; Zhang Q; Wang Q; Lai D
BMC Cancer; 2015 Dec; 15():956. PubMed ID: 26673159
[TBL] [Abstract][Full Text] [Related]
19. High ALDH activity defines ovarian cancer stem-like cells with enhanced invasiveness and EMT progress which are responsible for tumor invasion.
Li Y; Chen T; Zhu J; Zhang H; Jiang H; Sun H
Biochem Biophys Res Commun; 2018 Jan; 495(1):1081-1088. PubMed ID: 29170132
[TBL] [Abstract][Full Text] [Related]
20. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
